未登录

S

Susie Huntington

University of London

H指数:12

被引数:321

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Estimating the potential health economic value of introducing universal opt-out testing for HIV in emergency departments in Italy

估算在意大利急诊室引入普遍自愿检测退出机制进行HIV检测的潜在卫生经济学价值

EUROPEAN JOURNAL OF PUBLIC HEALTH

IF3.9

2025-04-230

OA

Evidence from Europe on implementation, participation and performance of self-collection for cervical cancer screening

FUTURE ONCOLOGY

IF2.6

2024-10-240

OA

Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands

IF3.3

2023-12-063

OAAI

Assessing the clinical impact and resource use of a 30-minute chlamydia and gonorrhoea point-of-care test at three sexual health services

THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE

IF3.4

2021-12-022

OAAI

Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with standard care in England sexual health clinics

EUROSURVEILLANCE

IF7.8

2020-10-296

OAAI

EVALUATING THE COSTS, BENEFITS AND COST-EFFECTIVENESS OF MULTI-PATHOGEN POINT-OF-CARE TESTS FOR SEXUALLY TRANSMITTED INFECTIONS IN SYMPTOMATIC GENITOURINARY MEDICINE CLINIC ATTENDEES

SEXUALLY TRANSMITTED INFECTIONS

IF2.9

2017-07-081

OAAI

COST-EFFECTIVENESS OF ANTIMICROBIAL RESISTANCE POINT-OF-CARE TESTING FOR OPTIMISING THE TREATMENT OF GONORRHOEA

SEXUALLY TRANSMITTED INFECTIONS

IF2.9

2017-07-080

OA

The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy

IF3.1

2015-11-0125

OAAI

Pregnancy is associated with elevation of liver enzymes in HIV-positive women on antiretroviral therapy

IF3.1

2015-04-249

OAAI

Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care

IF3.1

2013-01-0219

OAAI

Treatment switches during pregnancy among HIV-positive women on antiretroviral therapy at conception

IF3.1

2011-08-2412

OAAI